Clinical outcomes associated with the use of oral semaglutide in an adult population with type 2 diabetes in Canada: a prospective real-world study (PIONEER REAL Canada)

被引:0
|
作者
Reichert, S. M. [1 ,2 ]
Amadid, H. [3 ]
Braae, U. C. [3 ]
Bradley, R. M. [4 ]
Kim, J. [5 ]
Soo, V. [6 ]
Yale, J. -F. [7 ]
Jain, A. [8 ]
机构
[1] Western Univ, Schulich Sch Med & Dent, Dept Family Med, London, ON, Canada
[2] Western Univ, Schulich Sch Med & Dent, Ctr Studies Family Med, London, ON, Canada
[3] Novo Nordisk AS, Soborg, Denmark
[4] Novo Nordisk Inc, Mississauga, ON, Canada
[5] Univ Calgary, Dept Family Med, Calgary, AB, Canada
[6] Western Univ, Dept Family Med, London, ON, Canada
[7] McGill Univ, McGill Univ Hlth Ctr, Montreal, PQ, Canada
[8] Univ British Columbia, Div Endocrinol & Metab, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
668
引用
收藏
页码:S338 / S339
页数:2
相关论文
共 50 条
  • [21] Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes
    Candido, Riccardo
    Gaiotti, Sara
    Giudici, Fabiola
    Toffoli, Barbara
    De Luca, Federica
    Velardi, Valerio
    Petrucco, Alessandra
    Gottardi, Chiara
    Manca, Elena
    Buda, Iris
    Fabris, Bruno
    Bernardi, Stella
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [22] Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study
    Gorgojo-Martinez, Juan J.
    Gargallo-Fernandez, Manuel A.
    Sanz-Pastor, Alba Galdon
    Anton-Bravo, Teresa
    Brito-Sanfiel, Miguel
    Wong-Cruz, Jaime
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 18
  • [23] A district general hospital real-world experience of the use of semaglutide in patients with type 2 diabetes
    Liarakos, A. L.
    Smith, L.
    Patel, K.
    Mani, H.
    Pierides, M.
    DIABETIC MEDICINE, 2020, 37 : 131 - 131
  • [24] Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
    Williams, David M.
    Alberts, Barbara-Alex
    Sharaf, Asem
    Sharaf, Giselle
    Bain, Stephen C.
    Kalhan, Atul
    Min, Thinzar
    DIABETES THERAPY, 2024, 15 (07) : 1639 - 1646
  • [25] Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study
    Abitbol, Alexander
    Jain, Akshay B.
    Tsoukas, Michael A.
    Sigalas, John
    Galm, Brandon P.
    Lee, Jooho
    Qureshy, Kamran S.
    Collins, Caitlyn
    Woo, Vincent C.
    DIABETES & VASCULAR DISEASE RESEARCH, 2024, 21 (03):
  • [26] Semaglutide in Patients with Type 2 Diabetes: Real-World Data from Spain
    Cardenas-Salas, Jersy J.
    Sierra, Roberto
    Luiza Luca, Bogdana
    Sanchez, Begona
    Modrono, Naiara
    Casado, Carlos
    Sanchez, Nancy M.
    Cruces, Eva
    Vazquez, Clotilde
    DIABETES, 2021, 70
  • [27] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Holmes, Patrick
    Bell, Heather Elizabeth
    Bozkurt, Karan
    Catarig, Andrei-Mircea
    Clark, Alice
    Machell, Alena
    Sathyapalan, Thozhukat
    DIABETES THERAPY, 2021, 12 (11) : 2891 - 2905
  • [28] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Patrick Holmes
    Heather Elizabeth Bell
    Karan Bozkurt
    Andrei-Mircea Catarig
    Alice Clark
    Alena Machell
    Thozhukat Sathyapalan
    Diabetes Therapy, 2021, 12 : 2891 - 2905
  • [29] A real-world observational study of somatostatin analogue use and costs in Canada
    Cheung, Winson Y.
    Feuilly, Marion
    Laforty, Callahan
    Liovas, Anna
    McKechnie, Heather
    Loree, Jonathan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)
    Furusawa, Sho
    Nomoto, Hiroshi
    Oba-Yamamoto, Chiho
    Takeuchi, Jun
    Ito, Miki
    Kurihara, Hiroyoshi
    Aoki, Shin
    Miya, Aika
    Kameda, Hiraku
    Nakamura, Akinobu
    Atsumi, Tatsuya
    ENDOCRINE JOURNAL, 2024, 71 (06) : 603 - 616